Jupiter Investment Management’s Biogen BIIB Stock Holding History

Jupiter Investment Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	$35.1M	Buy	131,042 +82,612	+171%	+$24.8M	0.56%	50
2020 Q1	$15.3M	Sell	48,430 -76,936	-61%	-$23.3M	0.3%	92
2019 Q4	$37.2M	Buy	125,366 +40,859	+48%	+$11.3M	0.52%	56
2019 Q3	$19.7M	Buy	84,507 +29,958	+55%	+$6.98M	0.25%	115
2019 Q2	$12.8M	Sell	54,549 -613,204	-92%	-$142M	0.13%	148
2019 Q1	$158M	Buy	667,753 +244,326	+58%	+$76.9M	1.46%	23
2018 Q4	$127M	Sell	423,427 -195,678	-32%	-$62.4M	1.13%	29
2018 Q3	$219M	Buy	+619,105	New	+$213M	1.49%	19
2018 Q2	–	Sell	-896,844	Closed	-$246M	–	376
2018 Q1	$246M	Buy	896,844 +250,926	+39%	+$77.9M	1.96%	5
2017 Q4	$206M	Buy	645,918 +45,962	+8%	+$14.7M	1.9%	12
2017 Q3	$188M	Buy	599,956 +114,455	+24%	+$33.9M	1.96%	5
2017 Q2	$132M	Sell	485,501 -41,571	-8%	-$11M	1.6%	16
2017 Q1	$144M	Buy	527,072 +94,500	+22%	+$26.7M	2.04%	6
2016 Q4	$123M	Buy	432,572 +45,835	+12%	+$13.6M	2.11%	7
2016 Q3	$121M	Sell	386,737 -35,555	-8%	-$10.5M	2.1%	7
2016 Q2	$102M	Buy	422,292 +104,178	+33%	+$27.5M	1.91%	7
2016 Q1	$82.8M	Buy	318,114 +103,761	+48%	+$27.4M	1.7%	7
2015 Q4	$65.7M	Buy	214,353 +128,912	+151%	+$37M	1.75%	12
2015 Q3	$24.9M	Sell	85,441 -84,762	-50%	-$28M	0.7%	47
2015 Q2	$68.8M	Buy	170,203 +21,087	+14%	+$8.46M	2%	6
2015 Q1	$63M	Sell	149,116 -10,325	-6%	-$4.07M	2%	6
2014 Q4	$54.1M	Buy	159,441 +82,231	+107%	+$26.6M	1.92%	4
2014 Q3	$25.5M	Buy	+77,210	New	+$25.5M	1.26%	24
2014 Q1	–	Sell	-7,465	Closed	-$2.09M	–	340
2013 Q4	$2.09M	Sell	7,465 -50,697	-87%	-$13.1M	0.18%	157
2013 Q3	$14M	Buy	58,162 +16,594	+40%	+$3.71M	1.33%	6
2013 Q2	$8.95M	Buy	+41,568	New	+$8.88M	1.08%	12

Other funds holding BIIB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Jupiter Investment Management's BIIB Position: Q2 2020 in Review

Jupiter Investment Management increased its Biogen (BIIB) stake by 171% in Q2 2020, buying an estimated $24.8M and bringing the position to 131,042 shares worth $35.1M. The position accounts for 0.56% of the portfolio, ranked #50.

Jupiter Investment Management first reported a position in BIIB in Q2 2013 and has held it in 26 quarters since. The position peaked at $246M in Q1 2018. 1,060 funds tracked by Wall St. Rank hold BIIB as of Q2 2020.

Jupiter Investment Management held 131,042 shares of Biogen worth $35.1M as of Q2 2020.
Jupiter Investment Management bought 82,612 Biogen shares in Q2 2020, an estimated $24.8M.
Biogen made up 0.56% of Jupiter Investment Management's portfolio in Q2 2020, its #50 holding.
Jupiter Investment Management first reported a position in Biogen in Q2 2013 and has held it in 26 quarters since.
Jupiter Investment Management's Biogen position peaked at $246M in Q1 2018.
1,060 funds tracked by Wall St. Rank held Biogen as of Q2 2020.

Based on Jupiter Investment Management's 13F filing for Q2 2020, filed 13 Jul 2020.